本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Syros Pharmaceuticals Inc.

0.0874
-0.0050-5.41%
成交量:365.58万
成交额:33.21万
市值:234.52万
市盈率:-0.03
高:0.0998
开:0.0996
低:0.0855
收:0.0924
数据加载中...
2025/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/10

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/03/05

重要事件披露

Form 8-K - Current report
2025/02/28

重要事件披露

Form 8-K - Current report